Editor's Pick
The company said the results highlight precision oncology implementation challenges and its test's ability to help overcome these issues.
The Indian liquid biopsy company recently launched its Trublood tests for prostate cancer and pan-cancer detection using circulating tumor cells.
Philips has automated the informatics pipeline for NYU Langone's pan-cancer LDT and integrated its Genomics Workspace software with the health system's Epic EMR.
State-Regulated Illinois Health Plans Subject to Biomarker Test Coverage Mandate Starting 2022
Premium
The law requires state employee, Medicaid, public school, and small employer plans to cover evidence-based biomarker testing, a change that will readily impact cancer patients.
Natera Minimal Residual Disease Test Predicts Oligometastatic CRC Patient Outcomes in New Study
Premium
Investigators analyzed blood samples from patients at two time points after curative-intent surgery, finding that ctDNA MRD status was highly predictive of outcome.